From the June 2018 issue of HealthCare Business News magazine
HCB News: In 2015 IMRIS changed ownership. Can you tell us about that process and how it has impacted the company?
AF: In August 2015, we received backing from our parent company, Deerfield Management. At that time we reorganized and realigned ourselves under new leadership and with a renewed focus on neurosurgery. Since then, we’ve seen record earnings and significant growth in personnel, as well as new product developments, consulting services, and continued customer support. In 2017, our strong financial performance was driven by 67 percent growth in system bookings. We added 25 new personnel and unveiled a new corporate brand identity that better communicates our position in the industry and our focus on the human impact of our work – for physicians, hospital administrators and, most importantly, patients and their families.
Celebrating our two-year anniversary under new ownership last year was quite memorable for us. It’s been an incredible couple of years of growth. The internal alignment we now have, along with a pipeline of innovation, is energizing us to have a greater impact on both the medical experience and the human experience.
HCB News: What kind of news can we expect from IMRIS throughout the rest of the year and perhaps beyond that?
AF: Customers are inquiring about the option of a fixed MRI scanner and a stand-alone neuro-interventional angiography. If a facility is not able to undertake the construction for a moving scanner option, we want to provide the customer with an alternate solution that will provide the same high-quality imaging during the procedure. The solution would be to offer them a stationary scanner. We also have active projects in patient positioning and head fixation, and we are investigating the possibility of new types of coils.
Back to HCB News
